Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „expected“
Suchtreffer
Begriffe & Kennungen
Beyfortus · 4.5 · Since nirsevimab is a monoclonal antibody, a passive immunisation specific for RSV, it is not expected to inte
Eintrag öffnenBiktarvy · 4.5 · No interaction is expected with bictegravir and emtricitabine. IMMUNOSUPPRESSANTS Ciclosporin (IV or oral use)
Eintrag öffnenBiopoin · 4.8 · Summary of the safety profile Approximately 9% of patients can be expected to experience an adverse reaction.
Eintrag öffnenBuvidal · 4.5 · 8 expected to have less effects on buprenorphine metabolism when co-administered with Buvidal as compared to w
Eintrag öffnenCapecitabine Accord · 4.3 · • History of severe and unexpected reactions to fluoropyrimidine therapy, • Hypersensitivity to capecitabine o
Eintrag öffnenCasgevy · 4.5 · No formal drug interaction studies have been performed. Casgevy is not expected to interact with the hepatic c
Eintrag öffnenCasgevy · 4.8 · The safety profile was generally consistent with that expected from busulfan myeloablative conditioning and HS
Eintrag öffnenCellCept · 4.5 · 49 4.4). Conversely, changes of MPA exposure should be expected when switching patients from CsA to one of the
Eintrag öffnenCellCept · 4.8 · 79 transplant patients did not reveal any unexpected changes in incidence of malignancy compared to the 1-year
Eintrag öffnenCelsentri · 4.5 · 12 Ribavirin Ribavirin has not been studied, no CELSENTRI 300 mg interaction is expected. twice daily and riba
Eintrag öffnenCelsunax · 4.5 · Dopamine agonists and antagonists acting on the postsynaptic dopamine receptors are not expected to interfere
Eintrag öffnenCholestagel · 4.5 · Statins When Cholestagel was co-administered with statins in clinical studies, an expected add-on LDL-C loweri
Eintrag öffnenCialis · 4.5 · Cytochrome P450 metabolised medicinal products Tadalafil is not expected to cause clinically significant inhib
Eintrag öffnenCialis · 4.5 · Cytochrome P450 metabolised medicinal products Tadalafil is not expected to cause clinically significant inhib
Eintrag öffnenCialis · 4.5 · Cytochrome P450 metabolised medicinal products Tadalafil is not expected to cause clinically significant inhib
Eintrag öffnenColumvi · 4.5 · No interaction studies have been performed. No interactions with Columvi are expected via the cytochrome P450
Eintrag öffnenControloc Control · 4.8 · Approximately 5% of patients can be expected to experience adverse reactions.
Eintrag öffnenCopalia HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenCystagon · 4.8 · Approximately 35% of patients can be expected to experience adverse reactions. These mainly involve the gastro
Eintrag öffnenCystagon · 4.8 · Approximately 35% of patients can be expected to experience adverse reactions. These mainly involve the gastro
Eintrag öffnen